The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Relifex 1g film-coated tablets

1 gram(s) Film-coated tablet

Mylan IRE Healthcare LimitedPA2010/036/002

Main Information

Trade NameRelifex 1g film-coated tablets
Active SubstancesNabumetone
Strength1 gram(s)
Dosage FormFilm-coated tablet
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/036/002

Group Information

ATC CodeM01AX Other antiinflammatory and antirheumatic agents, non-steroids
M01AX01 nabumetone

Status

Authorised/WithdrawnAuthorised
Licence Issued16/10/2009
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back